Skip to main content
Clinical Trials/NCT05837676
NCT05837676
Recruiting
Not Applicable

Problem-Solving Training for Concussion (PST-Concussion): A Brief, Skills-Focused Intervention to Improve Functional Outcomes in Veterans With mTBI and Co-occurring Mental Health Symptoms

VA Office of Research and Development1 site in 1 country134 target enrollmentOctober 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Brain Concussion
Sponsor
VA Office of Research and Development
Enrollment
134
Locations
1
Primary Endpoint
Brief Symptom Inventory-18 (BSI-18) Global Severity Index T-Score
Status
Recruiting
Last Updated
7 months ago

Overview

Brief Summary

Mild traumatic brain injury (mTBI), also known as concussion, is a common injury sustained by Veterans. While most individuals who sustain mTBI experience a complete recovery within several weeks of injury, many Veterans with history of mTBI report frequent and long-lasting neurobehavioral complaints and functional impairment. Though research suggests that these outcomes are strongly influenced by co-occurring conditions such as post-traumatic stress disorder, depression, and chronic pain, evidence-based interventions capable of addressing this wide array of concerns are lacking. This study seeks to address this gap by evaluating the effectiveness of a brief and flexible behavioral health treatment (Problem-Solving Training for Concussion, or PST-Concussion), which was designed to be delivered by generalist providers working in VA primary care settings. If PST-Concussion is shown to be effective, this skills-focused intervention may help improve Veterans' recovery experience following mTBI.

Detailed Description

This study will be a longitudinal randomized two-arm parallel group clinical trial. Participants will be randomized 1:1 to either PST-Concussion or treatment as usual (TAU). Participants assigned to PST-Concussion will receive six, approximately 30-minute telehealth treatment sessions. Assessments will include standard self-report and cognitive measures that will be administered at baseline, post-treatment, and three-month follow-up. The primary objective of this study will be to evaluate the effectiveness of PST-Concussion in reducing psychological distress compared to TAU. Secondary and tertiary objectives will be to evaluate whether PST-Concussion is associated with appreciable change in subjective neurocognitive functioning, objective neurocognitive functioning, psychosocial functioning, and disability and quality of life. Multi-level modeling will be used to evaluate treatment effects at post-treatment and three-month follow-up. A test of non-inferiority will be conducted to evaluate the potential durability of observed treatment effects from post-test to follow-up. A portion of participants assigned to PST-Concussion will also be interviewed at post-treatment or follow-up to gain insight into the practical impact of intervention on psychosocial functioning and quality of life.

Registry
clinicaltrials.gov
Start Date
October 1, 2023
End Date
September 30, 2027
Last Updated
7 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • English-speaking Veteran enrolled in VHA care;
  • History of concussion (mild traumatic brain injury or mTBI);
  • Current psychological distress;
  • Subjective neurocognitive symptoms of \>= 3 months.

Exclusion Criteria

  • Moderate to severe TBI or other major neurocognitive disorder;
  • Psychotic disorder (e.g., schizophrenia spectrum disorder, delusional disorder, bipolar or depressive disorder with psychotic features);
  • Acute suicidal ideation;
  • Inpatient psychiatric hospitalization within the past 12 months;
  • Other illness/ condition that would preclude or predictably influence ability to engage in study visits, as determined by the study team.

Outcomes

Primary Outcomes

Brief Symptom Inventory-18 (BSI-18) Global Severity Index T-Score

Time Frame: Up to 24 weeks

The BSI-18 is a brief measure of psychological distress brought about by common somatic and affective symptoms. It has been validated for use in patients with history of TBI and is appropriate for use in primary care. Similar to a previous trial of PST for mTBI, its Global Severity Index (GSI) T-score will serve as the primary outcome measure. GSI T-scores range from 30-80, with lower scores signaling an overall lower level of psychological distress.

Secondary Outcomes

  • Hopkins Verbal Learning Test-Revised (HVLT-R)(Up to 24 weeks)
  • Neurobehavioral Symptom Inventory (NSI)(Up to 24 weeks)
  • Inventory of Psychosocial Functioning (IPF)(Up to 24 weeks)
  • Wechsler Adult Intelligence Scale- Fourth Edition (WAIS-IV) Digit Span(Up to 24 weeks)
  • World Health Organization Quality of Life - BREF (WHOQOL-BREF)(Up to 24 weeks)

Study Sites (1)

Loading locations...

Similar Trials